Assessing the safety of increased outpatient cephalosporin use following the modification of penicillin allergy cross-reactivity alerts
Infection Control & Hospital Epidemiology · 2025
DOI: 10.1017/ice.2025.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2025. Verfasst von Bryan Schneider und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Care, University of Iowa Health Care, Iowa City, IA, USA. Hauptthemen laut MEDLINE: Cephalosporins, Drug Hypersensitivity, Penicillins, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background
Concerns about penicillin-cephalosporin cross-reactivity have historically led to conservative prescribing and avoidance of cephalosporins in patients with penicillin allergy labels, potentially causing suboptimal outcomes. Recent evidence suggests a lower risk of cross-reactivity, prompting a reassessment of alert systems.
Objective
To assess the impact of limited penicillin cross-reactivity alerts on outpatient cephalosporin use and the incidence of adverse reactions in a healthcare setting.
Methods
This retrospective cohort study compared cephalosporin prescribing and adverse reactions in patients labeled as penicillin-allergic before and after limiting penicillin cross-reactivity alerts in the electronic medical record at a large academic medical center.
Results
Among 17,174 patients (8,131 pre- and 9,043 post-implementation), there was a statistically significant increase in outpatient cephalosporin prescribing by 8% ( P < .001). The use of alternative antibiotic classes decreased. There was no statistically significant increase in adverse events pre- and post-implementation (0.036%–0.058%, P = .547), and no severe events were attributable to cross-reactivity. The alert modification reduced alerts by 92% ( P < .001).
Conclusion
The reduction of penicillin-cephalosporin cross-reactivity alerts was associated with increased cephalosporin use, without a significant increase in adverse reactions. This demonstrates that the practice is safe and decreases alert burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Care, University of Iowa Health Care, Iowa City, IA, USA.
- College of Pharmacy, University of Iowa, Iowa City, IA, USA.
- Department of Internal Medicine, Division of Allergy and Immunology, University of Iowa, Iowa City, IA, USA.
- Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Iowa, Iowa City, IA, USA.
- Department of Internal Medicine, Division of Infectious Diseases, University of Iowa, Iowa City, IA, USA.
ORCID-Profile: Bryan Schneider, Kelly M Percival, Lukasz D Weiner, Dilek Ince, Patrick Kinn
Zitieren
APA
Schneider, B., Percival, K. M., Rhinehart, A. M., Frye, J., McDanel, D. L., Bebout, K. L., Weiner, L. D., Auerbach, S. A., Dowden, A. M., Ince, D., & Kinn, P. (2025). Assessing the safety of increased outpatient cephalosporin use following the modification of penicillin allergy cross-reactivity alerts. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2025.9
Vancouver
Schneider B, Percival KM, Rhinehart AM, Frye J, McDanel DL, Bebout KL, et al. Assessing the safety of increased outpatient cephalosporin use following the modification of penicillin allergy cross-reactivity alerts. Infection Control & Hospital Epidemiology. 2025. doi:10.1017/ice.2025.9
BibTeX
@article{Schneider2025,
author = {Schneider, Bryan and Percival, Kelly M and Rhinehart, Anna M and Frye, Jared and McDanel, Deanna L and Bebout, Kevin L and Weiner, Lukasz D and Auerbach, Sarah A and Dowden, Amy M and Ince, Dilek and Kinn, Patrick},
title = {Assessing the safety of increased outpatient cephalosporin use following the modification of penicillin allergy cross-reactivity alerts},
journal = {Infection Control & Hospital Epidemiology},
year = {2025},
doi = {10.1017/ice.2025.9}
}
EUVIMED